The potential of artificial intelligence in clinical trials
European Journal of Clinical Investigation · 2026-03 · 56 (3)
DOI: 10.1111/eci.70182 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift European Journal of Clinical Investigation, online erschienen am 27.02.2026. Verfasst von Rahul Aggarwal und 1 weiteren Autor:innen. Beteiligte Einrichtung: Brigham and Women's Hospital Heart and Vascular Center, Harvard Medical School, Boston, Massachusetts, USA. Hauptthemen laut MEDLINE: Artificial Intelligence, Clinical Trials as Topic. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 99 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NHLBI NIH HHS, National Heart, Lung, and Blood Institute.
Abstract (Originalsprache)
Background
Clinical trials are an important part of evidence generation in medicine but remain burdened by escalating costs, inefficiencies and manual processes. Artificial intelligence (AI) has emerged as a promising approach to address these limitations by improving efficiency across the trial lifecycle.
Methods
In this review, we examine emerging applications of AI across the clinical trial lifecycle. We highlight key examples demonstrating feasibility and potential impact.
Results
AI‐based approaches show promise in optimizing trial design, improving recruitment, streamlining conduct and enhancing data interpretation. Despite the potential of AI in trials, challenges persist, including data quality, regulatory and privacy concerns, as well as infrastructure issues. Ethical use will require strong governance frameworks emphasizing transparency and human oversight. The success of these technologies will depend on their continuous validation and monitoring of these technologies.
Conclusions
With appropriate validation, monitoring and governance, AI could enable a more efficient, cost‐saving and effective clinical trial landscape that accelerates discovery.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Brigham and Women's Hospital Heart and Vascular Center, Harvard Medical School, Boston, Massachusetts, USA.
- Massachussetts Institute of Technology, Cambridge, Massachusetts, USA.
- Mount Sinai Fuster Heart Hospital, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
ORCID-Profile: Rahul Aggarwal, Deepak L Bhatt
Förderung
- NHLBI NIH HHS
- National Heart, Lung, and Blood Institute
Zitieren
APA
Aggarwal, R., & Bhatt, D. L. (2026). The potential of artificial intelligence in clinical trials. European Journal of Clinical Investigation, 56(3). https://doi.org/10.1111/eci.70182
Vancouver
Aggarwal R, Bhatt DL. The potential of artificial intelligence in clinical trials. European Journal of Clinical Investigation. 2026;56(3). doi:10.1111/eci.70182
BibTeX
@article{Aggarwal2026,
author = {Aggarwal, Rahul and Bhatt, Deepak L},
title = {The potential of artificial intelligence in clinical trials},
journal = {European Journal of Clinical Investigation},
year = {2026},
volume = {56},
number = {3},
doi = {10.1111/eci.70182}
}
EUVIMED